Abstract:Background: Succinate is a well-known intermediate in the tricarboxylic acid (Krebs) cycle, where it is converted to form fumarate by succinate dehydrogenase from succinyl-CoA. Surprisingly, besides as a general metabolic intermediate, succinate can selectively activate orphan G receptor GPR91, which is highly expressed in the kidney, including glomerular vasculature, the macula densa (MD), proximal tubules, distal tubules, the cortical thick ascending limb of (cTAL) Henle’s loop, and the cortical as well as medullary collecting duct (CD). The level of succinate in patients with type 2 diabetes and obesity was much higher than healthy controls. However, the causative role of succinate in renal function is still unknown. Considering the excess succinate concentration, abundant expression of GPR91, and the importance of the kidney, we speculated that succinate could affect renal function. Methods: Male C57 BL/6 mice provided sterile drinking water containing 4% succinate ad libitum for 8 weeks and 12 weeks were used to investigate the effect of succinate on important renal functions. Results: Succinate administration markedly promoted water reabsorption via upregulating AQP2 protein and gene expression. Furthermore, Na + retention was significantly enhanced by succinate via increasing ENaC protein and gene expression. Moreover, succinate caused severe damage to the kidney, including glomerulus and proximal tubule, and tubulointerstitial fibrosis. These pathological changes were consistent with characteristics reported in diabetic kidney disease both in clinical patients and animal models. Conclusions: Other than a common metabolic intermediate in the Krebs cycle, elevated succinate in the circulation causes renal dysfunction and damage and recapitulates a diabetes-like phenotype of kidney disease, indicating that eliminating succinate from blood may improve clinic intervention in diabetic kidney disease. Funding Information: This study was supported by the National Natural Science Foundation of China (Grants 82070888, 82070882, 81770808, 81872165, 81701414, 81871211, and 81702879); National Key RD Guangdong Provincial Key RD Key Project of Nature Science Foundation of Guangdong Province, China (Grant 2019B1515120077); Guangdong Natural Science Fund (Grant 2019A1515011810, 2021A1515010434); Guangdong Science Technology Project (Grant 2017A020215075); Key Sci-Tech Research Project of Guangzhou Municipality, China (Grants 201803010017, 201807010069, and 202002020022); 2017 and 2019 Milstein Medical Asian American Partnership Foundation Research Project Award in Translational Medicine. Declaration of Interests: None. Ethics Approval Statement: All animal procedures were approved by the Animal Care and Use Committee of Sun Yat-Sen University (Ethics Committee of ZSSOM on Laboratory Animal Care No. 2020001017; Guangzhou, China).

Gut microbiota-derived succinate aggravates acute lung injury after intestinal ischaemia/reperfusion in mice

Pulmonary Succinate Receptor 1 Elevation in High-Fat Diet Mice Exacerbates Lipopolysaccharides-Induced Acute Lung Injury Via Sensing Succinate

Targeting Alveolar-Specific Succinate Dehydrogenase A Attenuates Pulmonary Inflammation During Acute Lung Injury.

[Protective Effects and Mechanisms of Recombinant Human Superoxide Dismutase in Acute Lung Injury of Rats Following Meconium Aspiration].

Succinate pretreatment attenuates intestinal ischemia-reperfusion injury by inhibiting necroptosis and inflammation via upregulating Klf4

Succinate promotes pulmonary fibrosis through GPR91 and predicts death in idiopathic pulmonary fibrosis

Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS

Succinate Induces Aberrant Mitochondrial Fission in Cardiomyocytes Through GPR91 Signaling

Lactobacillus Reuteri Ameliorates Lipopolysaccharide-Induced Acute Lung Injury by Modulating the Gut Microbiota in Mice.

Succinate/IL-1β Signaling Axis Promotes the Inflammatory Progression of Endothelial and Exacerbates Atherosclerosis

Succinate metabolism and its regulation of host-microbe interactions

Succinate Accumulation Impairs Cardiac Pyruvate Dehydrogenase Activity Through GRP91-dependent and Independent Signaling Pathways: Therapeutic Effects of Ginsenoside Rb1.

Succinate signaling attenuates high-fat diet-induced metabolic disturbance and intestinal barrier dysfunction

Sphingosine-1-Phosphate Attenuates Lung Injury Induced by Intestinal Ischemia/Reperfusion in Mice: Role of Inducible Nitric-Oxide Synthase

Succinate activates UCP2 to suppress neuroinflammation and confer protection following intracerebral hemorrhage

SIRT1-Rab7 axis attenuates NLRP3 and STING activation through late endosomal-dependent mitophagy during sepsis-induced acute lung injury

Assessing the impact of gut microbiota and metabolic products on acute lung injury following intestinal ischemia-reperfusion injury: harmful or helpful?

Succinate communicates pro-inflammatory signals to the host and regulates bile acid enterohepatic metabolism in a pig model.

Untargeted metabolomics identifies succinate as a biomarker and therapeutic target in aortic aneurysm and dissection

Succinate Recapitulates a Diabetes-Like Phenotype of Renal Dysfunction and Injury in the Absence of Hyperglycemia

Succinate accumulation drives ischaemia-reperfusion injury during organ transplantation